The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AADI BIOSCIENCE INC | COM | 00032Q104 | 4,273,178 | 590,218 | SH | SOLE | 0 | 0 | 0 | ||
ACLARIS THERAPEUTICS INC | COM | 00461U105 | 35,583,485 | 4,398,453 | SH | SOLE | 0 | 0 | 0 | ||
ACUMEN PHARMACEUTICALS INC | SPONSORED ADS | 00509G209 | 39,669,338 | 9,770,773 | SH | SOLE | 0 | 0 | 0 | ||
AEROVATE THERAPEUTICS INC | COM | 008064107 | 166,684,517 | 8,263,982 | SH | SOLE | 0 | 0 | 0 | ||
ALPINE IMMUNE SCIENCES INC | COMMON STOCK | 02083G100 | 36,192,248 | 4,688,115 | SH | SOLE | 0 | 0 | 0 | ||
ARS PHARMACEUTICALS INC | COM | 82835W108 | 19,593,004 | 3,009,678 | SH | SOLE | 0 | 0 | 0 | ||
ASCENDIS PHARMA A/S | COM | 04351P101 | 745,948,732 | 6,957,179 | SH | SOLE | 0 | 0 | 0 | ||
BELLUS HEALTH INC NEW | COM | 07987C204 | 91,033,733 | 12,643,574 | SH | SOLE | 0 | 0 | 0 | ||
BIOGEN INC | COM | 09062X103 | 148,159,963 | 532,892 | SH | SOLE | 0 | 0 | 0 | ||
BLACK DIAMOND THERAPEUTICS I | COM | 09203E105 | 4,894,919 | 2,589,904 | SH | SOLE | 0 | 0 | 0 | ||
CELCUITY INC | COM | 15102K100 | 14,350,010 | 1,400,001 | SH | SOLE | 0 | 0 | 0 | ||
COGENT COMMUNICATIONS HLDGS | COM | 19240Q201 | 64,734,400 | 5,999,481 | SH | SOLE | 0 | 0 | 0 | ||
CONNECT BIOPHARMA HLDGS LTD | CLASS A ORD SHS | 207523101 | 6,990,304 | 6,991,003 | SH | SOLE | 0 | 0 | 0 | ||
CYTEK BIOSCIENCES INC | SPONSORED ADR | 23285D109 | 122,971,886 | 13,381,054 | SH | SOLE | 0 | 0 | 0 | ||
DICE THERAPEUTICS INC | COM | 23345J104 | 225,091,934 | 7,856,612 | SH | SOLE | 0 | 0 | 0 | ||
DAY ONE BIOPHARMACEUTICALS I | COM | 23954D109 | 94,133,116 | 7,040,622 | SH | SOLE | 0 | 0 | 0 | ||
DESIGN THERAPEUTICS INC | COM | 25056L103 | 17,144,003 | 2,971,231 | SH | SOLE | 0 | 0 | 0 | ||
89BIO INC | COM | 282559103 | 173,880,118 | 11,416,948 | SH | SOLE | 0 | 0 | 0 | ||
ELIEM THERAPEUTICS INC | COM | 28658R106 | 38,137,462 | 13,150,849 | SH | SOLE | 0 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 46,481,984 | 2,122,465 | SH | SOLE | 0 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM | 30233G209 | 9,909,288 | 3,370,506 | SH | SOLE | 0 | 0 | 0 | ||
FULCRUM THERAPEUTICS INC | COM | 359616109 | 33,087,656 | 11,609,704 | SH | SOLE | 0 | 0 | 0 | ||
FUSION PHARMACEUTICALS INC | COM | 36118A100 | 2,488,170 | 659,992 | SH | SOLE | 0 | 0 | 0 | ||
GERON CORP | ADS | 374163103 | 68,452,229 | 31,544,806 | SH | SOLE | 0 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 29,093,114 | 1,760,019 | SH | SOLE | 0 | 0 | 0 | ||
ICOSAVAX INC | COM | 45114M109 | 34,588,677 | 5,963,565 | SH | SOLE | 0 | 0 | 0 | ||
IMMUNOGEN INC | CLASS A COM | 45253H101 | 83,919,199 | 21,853,958 | SH | SOLE | 0 | 0 | 0 | ||
INHIBRX INC | COM | 45720L107 | 72,722,470 | 3,853,867 | SH | SOLE | 0 | 0 | 0 | ||
ITEOS THERAPEUTICS INC | SPONSORED ADR | 46565G104 | 60,118,895 | 4,417,259 | SH | SOLE | 0 | 0 | 0 | ||
JANUX THERAPEUTICS INC | COM | 47103J105 | 104,914,792 | 8,670,644 | SH | SOLE | 0 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 26,650,900 | 4,264,144 | SH | SOLE | 0 | 0 | 0 | ||
MINERALYS THERAPEUTICS INC | COM | 603170101 | 49,774,934 | 3,178,476 | SH | SOLE | 0 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES | SHS | 63009R109 | 24,327,003 | 2,457,273 | SH | SOLE | 0 | 0 | 0 | ||
NKARTA INC | COM | 65487U108 | 27,708,208 | 7,805,129 | SH | SOLE | 0 | 0 | 0 | ||
PEPGEN INC | COM | 713317105 | 99,453,773 | 8,131,952 | SH | SOLE | 0 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 46,869,200 | 1,762,000 | SH | SOLE | 0 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 19,387,306 | 1,131,775 | SH | SOLE | 0 | 0 | 0 | ||
RXSIGHT INC | ORDINARY SHARES | 78349D107 | 50,920,637 | 3,052,796 | SH | SOLE | 0 | 0 | 0 | ||
SATSUMA PHARMACEUTICALS INC | ORD SHS | 80405P107 | 4,131,105 | 5,914,252 | SH | SOLE | 0 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM | 83422E204 | 16,240,596 | 3,426,286 | SH | SOLE | 0 | 0 | 0 | ||
TENAYA THERAPEUTICS INC | COM | 87990A106 | 17,292,327 | 6,067,483 | SH | SOLE | 0 | 0 | 0 | ||
TYRA BIOSCIENCES INC | COM | 90240B106 | 116,289,816 | 7,236,454 | SH | SOLE | 0 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 273,276,200 | 7,291,254 | SH | SOLE | 0 | 0 | 0 | ||
VERONA PHARMA PLC | COM | 925050106 | 126,865,239 | 6,317,990 | SH | SOLE | 0 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 51,082,146 | 2,007,946 | SH | SOLE | 0 | 0 | 0 | ||
VOR BIOPHARMA INC | COM | 929033108 | 122,388,974 | 22,748,880 | SH | SOLE | 0 | 0 | 0 | ||
WEREWOLF THERAPEUTICS INC | COM | 95075A107 | 15,976,691 | 6,144,881 | SH | SOLE | 0 | 0 | 0 | ||
GH RESEARCH PLC | COM | G3855L106 | 44,593,476 | 5,581,161 | SH | SOLE | 0 | 0 | 0 | ||
ENTERA BIO LTD | COM | M40527109 | 343,321 | 295,966 | SH | SOLE | 0 | 0 | 0 | ||
CUREVAC N V | SPONSORED ADS | N2451R105 | 85,354,306 | 12,245,955 | SH | SOLE | 0 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | COM | N62509109 | 53,040,000 | 4,000,000 | SH | SOLE | 0 | 0 | 0 | ||
NEWAMSTERDAM PHARMA COMPANY | *W EXP 11/22/202 | N62509117 | 613,333 | 333,333 | SH | SOLE | 0 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | COM | Y95308105 | 74,484,699 | 17,202,009 | SH | SOLE | 0 | 0 | 0 | ||
AN2 THERAPEUTICS INC | COM | 037326105 | 37,244,613 | 3,773,517 | SH | SOLE | 0 | 0 | 0 | ||
AVIDITY BIOSCIENCES INC | COM | 05370A108 | 98,500,919 | 6,416,998 | SH | SOLE | 0 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM | 15117B202 | 62,424,293 | 1,734,972 | SH | SOLE | 0 | 0 | 0 | ||
LEGEND BIOTECH CORP | COM | 52490G102 | 117,474,673 | 2,436,223 | SH | SOLE | 0 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 98,406,635 | 5,516,067 | SH | SOLE | 0 | 0 | 0 | ||
ACRIVON THERAPEUTICS INC | COM | 004890109 | 61,045,347 | 4,810,508 | SH | SOLE | 0 | 0 | 0 |